6-K

NOTICE OF RESULTS

Company: Indivior Pharmaceuticals, Inc.
Filed: February 4, 2025
Period of Report: February 4, 2025
Accession Number: 0001654954-25-001135

View Document ↗ View on SEC.gov ↗